Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biological Consequences of MHC-II Expression by Tumor Cells in Cancer

21 Nov 2018

Abstract excerpt

Abstract Immunotherapy has emerged as a key pillar of cancer treatment. To build upon the recent successes of immunotherapy, intense research efforts are aimed at a molecular understanding of antitumor immune responses, identification of biomarkers of immunotherapy response and resistance, and novel strategies to circumvent resistance. These studies are revealing new insight into the intricacies of tumor cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30463850
DOI: 10.1158/1078-0432.ccr-18-3200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biological Consequences of MHC-II Expression by Tumor Cells in CancerPMID 30463850Read ↗

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.Semantic proximity Read ↗

Assessment of cancer cell‐expressed HLA class I molecules and their immunopathological implicationsSemantic proximity Read ↗

Malignant cell MHC-II immunopeptidomes reveal the evolution of tumor-host interactionsSemantic proximity Read ↗

MHC heterogeneity and response of metastases to immunotherapy.Semantic proximity Read ↗

HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activationSemantic proximity Read ↗

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.Semantic proximity Read ↗

Hippo Signaling Pathway Regulates Cancer Cell–Intrinsic MHC-II ExpressionSemantic proximity Read ↗

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune CellsSemantic proximity Read ↗

Altered MHC class I antigens in tumors.Semantic proximity Read ↗

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.Semantic proximity Read ↗

Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacySemantic proximity Read ↗

Pan-cancer HLA Gene-mediated Tumor Immunogenicity and Immune EvasionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.